European Cancer Congress

European Cancer Congress. The European Cancer Congress is a major European Society for Medical Oncology (ESMO) and European Cancer Organisation (ECCO) event, bringing together oncologists, cancer researchers, and healthcare professionals from around the world, including American Society of Clinical Oncology (ASCO) and National Cancer Institute (NCI) experts. This congress is attended by renowned specialists such as David Khayat, Josep Tabernero, and Fortunato Ciardiello, who share their knowledge on the latest cancer research and treatments, including immunotherapy and targeted therapy, as discussed in The Lancet Oncology and Journal of Clinical Oncology. The congress features presentations from esteemed institutions like Memorial Sloan Kettering Cancer Center, University of Texas MD Anderson Cancer Center, and Institut Gustave Roussy.

● Introduction

The European Cancer Congress is a premier oncology event that showcases the latest advancements in cancer diagnosis, cancer treatment, and cancer prevention, with contributions from organizations like International Agency for Research on Cancer (IARC) and World Health Organization (WHO). The congress provides a platform for researchers, clinicians, and patients to interact and discuss the latest developments in oncology, including precision medicine and personalized medicine, as highlighted in Nature Medicine and Science Translational Medicine. Attendees can expect to learn from experts like Vincent DeVita, Samuel Hellman, and James Allison, who have made significant contributions to the field of cancer research, including the development of chemotherapy and immunotherapy. The congress also features exhibits from leading pharmaceutical companies, such as Roche, Pfizer, and Merck, showcasing their latest cancer therapies and treatments.

● History

The European Cancer Congress has a rich history, dating back to the first European Cancer Conference held in 1981 in Amsterdam, organized by European Society for Medical Oncology (ESMO) and European Cancer Organisation (ECCO). Since then, the congress has grown in size and scope, with notable meetings held in Berlin (1993), Paris (1995), and Vienna (2000), featuring presentations from esteemed researchers like Harald zur Hausen and David Lane. The congress has also been held in other major European cities, including Barcelona (2003), Copenhagen (2005), and Stockholm (2008), with contributions from organizations like European Organisation for Research and Treatment of Cancer (EORTC) and International Union Against Cancer (UICC). Over the years, the congress has become a premier event in the oncology calendar, attracting thousands of attendees from around the world, including United States, China, and Japan.

● Organization

The European Cancer Congress is organized by the European Cancer Organisation (ECCO) and the European Society for Medical Oncology (ESMO), in collaboration with other leading cancer organizations, such as American Society of Clinical Oncology (ASCO) and National Cancer Institute (NCI). The congress is chaired by a renowned oncologist, such as David Khayat or Josep Tabernero, who is supported by a team of experts from European Institute of Oncology (IEO) and Institut Curie. The scientific program is developed by a committee of leading researchers and clinicians, including Fortunato Ciardiello and Paul Workman, who ensure that the congress features the latest and most relevant cancer research and treatments, as published in Journal of the National Cancer Institute and Cancer Research.

● Scientific Program

The scientific program of the European Cancer Congress features a wide range of plenary sessions, symposia, and workshops, covering topics such as cancer biology, cancer diagnosis, and cancer treatment, with presentations from experts like James Allison and Vincent DeVita. The program also includes poster sessions and exhibits, showcasing the latest cancer research and treatments, including immunotherapy and targeted therapy, as discussed in The Lancet Oncology and Nature Medicine. Attendees can expect to learn from leading researchers and clinicians, including Samuel Hellman and Harald zur Hausen, who have made significant contributions to the field of oncology, including the development of chemotherapy and radiation therapy.

● Attendance and Impact

The European Cancer Congress attracts thousands of attendees from around the world, including oncologists, researchers, and healthcare professionals, from institutions like Memorial Sloan Kettering Cancer Center and University of Texas MD Anderson Cancer Center. The congress has a significant impact on the field of oncology, with many attendees returning to their hospitals and research institutions inspired to implement new cancer treatments and research protocols, as discussed in Journal of Clinical Oncology and Cancer Research. The congress also provides a platform for collaboration and networking among attendees, with many research collaborations and clinical trials initiated as a result of the congress, involving organizations like National Institutes of Health (NIH) and European Commission.

● Notable Meetings

The European Cancer Congress has hosted many notable meetings over the years, including the 2013 congress in Amsterdam, which featured a plenary session on immunotherapy chaired by James Allison, and the 2015 congress in Vienna, which included a symposium on precision medicine chaired by Vincent DeVita. Other notable meetings have included the 2017 congress in Madrid, which featured a workshop on cancer diagnosis chaired by Fortunato Ciardiello, and the 2019 congress in Paris, which included a plenary session on cancer treatment chaired by Josep Tabernero. These meetings have showcased the latest advancements in oncology and have provided a platform for researchers and clinicians to share their knowledge and expertise, with contributions from organizations like American Cancer Society and Cancer Research UK.

Category:Oncology conferences